Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974158-23-000053
Filing Date
2023-09-29
Accepted
2023-09-29 16:26:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3054
  Complete submission text file 0001974158-23-000053.txt   4399
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Subject) CIK: 0001672619 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39247 | Film No.: 231296067
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address
Lyssikatos Joseph P (Reporting) CIK: 0001967150 (see all company filings)

Type: 144